Advanced Filters
noise
Found 65,447 clinical trials
B Bente Frisk, PHD

A Digital Health Intervention to Promote Self-management in Patients With Chronic Obstructive Pulmonary Disease

Dyspnea, cough, and chronic mucus hypersecretion are common symptoms in patients with Chronic Obstructive Pulmonary Disease (COPD), which increases risk of infections followed by exacerbations, often leading to hospitalization, disease progression and mortality. This patient group requires lifelong treatment in healthcare. A mobile application was developed to facilitate adherence to …

18 - 90 years of age All Phase N/A
M Mehmet Delen, PhD

Effectiveness of Scapular Exercises Compared To Conventional Treatment in Shoulder Pain

The contribution of the scapula to shoulder joint movement is great. The contribution of the scapula bone is more prominent, especially in overhead activities. Therefore, the position and movement of the scapula are generally examined in people with shoulder disease. Scapula-focused exercises are used in patients with shoulder problems. However, …

18 years of age All Phase N/A
M Melissa N Slavin, PhD

WORTH Paths Intervention

Women in the criminal legal system are more likely to experience substance use disorders and unintended pregnancy than women in the general public. However, they often face barriers to accessing substance use treatment and sexual and reproductive health services. This study tests the feasibility and acceptability of Women on the …

18 - 44 years of age Female Phase N/A
C Chengde Yang, Dr

Effect of Belimumab on Antibody Titers in Primary APS Patients

The purpose of this study is to evaluate the regulatory effect of Belimumab on the antiphospholipid antibody (aPL) as well as to observe related past and new clinical events in primary antiphospholipid syndrome patients.

18 years of age All Phase 2
L Lingli Dong, MD

Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

This is a single-center, open-label, exploratory clinical study to evaluate the efficacy and safety of Equecabtagene Autoleucel Injection (Eque-cel) in patients with Relapsed /refractory systemic lupus erythematosus (SLE).

18 years of age All Phase N/A

Foot Muscles Training in Sclerosis

The study tries to assess the efficacy of an 8-week IFM training programme on stability in patients diagnosed with Multiple Sclerosis

18 - 70 years of age All Phase N/A

HOPE At Heart (HOPE) of Donor Hearts After Circulatory Death (DCD) Using the XVIVO Heart Assist Transport System.

The purpose of the clinical investigation is to support the use of direct procurement of donor hearts in donation after circulatory death followed by hypothermic oxygenated perfusion using the XVIVO Heart Assist Transport System. Thereby increasing the utilization of DCD donor hearts in donation after circulatory death. The primary objective …

18 years of age All Phase N/A
Z Zhaohui Zhu, MD,PHD

99mTc-CNDG SPECT/CT in Brain Tumors

The goal of this clinical trial is to evaluate the value of 99mTc-CNDG for diagnosis of brain tumors by comparing it with 18F-FDG-PET. The main questions it aims to answer are: What is the diagnostic consistency between 99mTc-CNDG and 18F-FDG? What is the correlation between the SUVmax value of 99mTc-CNDG …

18 years of age All Phase N/A
H Hanguang Hu

Clinical Study of Second-line Treatment in Advanced Colorectal Cancer with Chemotherapy with Bevacizumab or Cetuximab

Guidelines recommend FOLFIRI in combination with bevacizumab or cetuximab as a treatment option for advanced second-line colorectal cancer, and this study explores the efficacy and safety of a clinical study of liposomal irinotecan (II), fluorouracil, in combination with bevacizumab or cetuximab for the second-line treatment of patients with advanced colorectal …

18 - 75 years of age All Phase 2
Ó Óscar Cano

Safety and Performance Evaluation of a New Catheter Range for Lead Implantation At Interventricular Septum

The purpose of the clinical investigation is to evaluate the safety of the FLEXIGO delivery catheter for transvenous pacing lead implantation.

18 years of age All Phase N/A

Simplify language using AI